Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Southeast Renal Research Institute (SERRI) is a dedicated clinical research center and a division of Nephrology Associates, located in Chattanooga, Tennessee. Founded in 2005, the institute specializes in conducting Phase I through IV clinical trials, as well as medical device and hospital-based studies, focused on nephrology and related metabolic conditions. SERRI provides a comprehensive research environment, featuring a CLIA-certified laboratory, advanced imaging capabilities, and a team of board-certified nephrologists and experienced research coordinators. The institute collaborates with major pharmaceutical and biotechnology companies to evaluate novel therapies for indications such as chronic kidney disease, lupus nephritis, IgA nephropathy, and anemia. By integrating research with a large clinical practice, SERRI offers patients access to cutting-edge treatments while contributing significant data to the global renal research community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Southeast Renal Research Institute.